140 reports of this reaction
3.4% of all RILPIVIRINE HYDROCHLORIDE reports
#4 most reported adverse reaction
ANHEDONIA is the #4 most commonly reported adverse reaction for RILPIVIRINE HYDROCHLORIDE, manufactured by Janssen Products, LP. There are 140 FDA adverse event reports linking RILPIVIRINE HYDROCHLORIDE to ANHEDONIA. This represents approximately 3.4% of all 4,147 adverse event reports for this drug.
Patients taking RILPIVIRINE HYDROCHLORIDE who experience anhedonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANHEDONIA is moderately reported among RILPIVIRINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to anhedonia, the following adverse reactions have been reported for RILPIVIRINE HYDROCHLORIDE:
The following drugs have also been linked to anhedonia in FDA adverse event reports:
ANHEDONIA has been reported as an adverse event in 140 FDA reports for RILPIVIRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANHEDONIA accounts for approximately 3.4% of all adverse event reports for RILPIVIRINE HYDROCHLORIDE, making it a notable side effect.
If you experience anhedonia while taking RILPIVIRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.